Charles S. Carter - Concepedia

Concepedia

Author

Charles S. Carter

National Institutes of Health

Also Known As

Charles S Carter, Charles S. Carter, Charles S. Carter

36

Publications

4.2K

Citations

21

H-Index

43

Concepts

All Affiliations

National Institutes of Health National Cancer Institute National Institutes of Health Clinical Center National Heart Lung and Blood Institute National Institute of Allergy and Infectious Diseases

CS

About

Charles S. Carter is an author at National Institutes of Health specializing in medicine, immunology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.2K
2	Cell Biology	8	8	1.1K
3	Health Sciences	1	1	135
4	Allergy	1	1	25
5	Blood Transplantation	1	1	64

Charles S. Carter

×

25

Publications

4.2K

Citations

21

H-Index

	Year	Citations
T Lymphocyte-Directed Gene Therapy for ADA <sup>−</sup> SCID: Initial Trial Results After 4 Years R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller, Science	1995	1.5K
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells Hua Zhang, Kevin Chua, Martin Guimond, Nature Medicine InflammationAutoimmune DiseaseLymphocyte DevelopmentT-regulatory CellImmunology	2005	373
Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease Harry L. Malech, Phillip B. Maples, Narda Whiting‐Theobald, Proceedings of the National Academy of Sciences	1997	342
Epidermal Cell Production of Thymocyte Activating Factor (ETAF) Daniel N. Sauder, Charles S. Carter, Stephen I. Katz, Journal of Investigative Dermatology Skin DevelopmentEpidermal Cell ProductionDermatologyMedicineCell Biology	1982	315
Treatment of Chronic Granulomatous Disease with Nonmyeloablative Conditioning and a T-Cell–Depleted Hematopoietic Allograft Mitchell E. Horwitz, A. John Barrett, Margaret R. Brown, New England Journal of Medicine	2001	273
Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response Barbara A. Pockaj, Richard M. Sherry, John P. Wei, Cancer	1994	201
Pilot trial of tumor‐specific peptide vaccination and continuous infusion interleukin‐2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter‐institute NIH study† Ramzi Dagher, Lauren Long, Elizabeth J. Read, Medical and Pediatric Oncology	2002	148
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation Scott R. Solomon, Stephan Mielke, Bipin N. Savani, Blood	2005	140
Engraftment of Hematopoietic Progenitor Cells Transduced with the Fanconi Anemia Group C Gene (FANCC) Johnson M. Liu, Sonnie Kim, Elizabeth J. Read, Human Gene Therapy Fanconi AnemiaCell TherapyBone Marrow FailureHealth SciencesGene Transduction	1999	135
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults Robert Walker, Charles S. Carter, Linda Muul, Nature Medicine Human RetrovirusT-regulatory CellImportant MeansImmunologyAutoimmunity	1998	118

Page 1